C
Centivax
$82M raised across 2 rounds tracked here. Latest: Venture, $37M on 25 March 2026.
- Total raised
- $82M
- Rounds
- 2
Latest round VentureCountry 🇺🇸United StatesSector Health
Rounds 2
$37MVenture, 25 March 2026
Oversubscribed round to take its universal flu vaccine into Phase 2.
- Amount
- $37M
- Stage
- Venture
- Announced
- 25 March 2026
- Lead
- Structure Fund
- Other investors
- Meiji Seika Pharma, Sigmas Group, Kendall Capital Partners, Patrick Collison, John Collison
- Use of funds
- Oversubscribed round to take its universal flu vaccine into Phase 2.
- Checked
- Announced by the company
- Sources
- Centivax raises $37M for universal flu vaccine biospace.com
Centivax raises $37M for universal flu vaccine pulse2.com
$45MSeries A, 8 July 2025
Funds CMC work and a Phase I trial of its universal flu vaccine candidate.
- Amount
- $45M
- Stage
- Series A
- Announced
- 8 July 2025
- Lead
- Future Ventures
- Other investors
- NFX, BOLD Capital Partners, Base4 Capital, Kendall Capital Partners, Amplify Partners
- Use of funds
- Funds CMC work and a Phase I trial of its universal flu vaccine candidate.
- Checked
- Amount and date matched across 3 press sources
- Sources
- Centivax Raises Oversubscribed $45 Million Series A Led by Future Ventures to Advance Universal Flu Vaccine in hitconsultant.net
Centivax Raises Oversubscribed $45 Million Series A Led by Future Ventures to Advance Universal Flu Vaccine in news.google.com
Centivax Raises Oversubscribed $45 Million Series A Led by Future Ventures to Advance Universal Flu Vaccine in techstartups.com
Questions
How much has Centivax raised?
Centivax has raised $82M across 2 rounds tracked by FundraiseBase. The latest is Venture of $37M, announced on 25 March 2026.
Who invested in Centivax?
Structure Fund and Future Ventures led. Investors include Structure Fund, Meiji Seika Pharma, Sigmas Group, Kendall Capital Partners, Patrick Collison and John Collison.
